Nuclear tyrosine kinases: From Abl to WEE1

Current Opinion in Cell Biology

Volumn 8, Issue 2, 1996, Pages 174-181

  Pendergast, Ann Marie ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; PROTEIN TYROSINE KINASE;

CELL CYCLE; CELL NUCLEUS; CYTOPLASM; DNA REPAIR; HUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0029924347     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(96)80063-9     Document Type: Article

References (46)

1. Bolen JB: Protein tyrosine kinases in the initiation of antigen receptor signaling. Curr Opin Immunol 1995, 7:306-311.
2. Weiss A, Littman DR: Signal transduction by lymphocyte antigen receptors. Cell 1994, 76:263-274.
3. Ihle JN: Cytokine receptor signaling. Nature 1995, 377:591-594.
4. Erpel T, Courtneidge SA: Src family protein tyrosine kinases and cellular signal transduction pathways. Curr Opin Cell Biol 1995, 7:176-182.
5. Morgan DO: Principles of CDK regulation. Nature 1995, 374:131-134.
6. 1 and exhibit elevated levels of chromosomal abnormalities.
7. Wang JYJ: Abl tyrosine kinase in signal transduction and cell-cycle regulation. Curr Opin Genet Dev 1993, 3:35-43.
8. Feller SM, Ren R, Hanafusa H, Baltimore D: SH2 and SH3 domains as molecular adhesives: the interactions of Crk and Abl. Trends Biochem Sci 1994, 19:453-458.
9. Lundgren K, Walworth N, Booher R, Dembski M, Kirschner M, Beach D: mik1 and wee1 cooperate in the inhibitory tyrosine phosphorylation of cdc2. Cell 1991, 64:1111-1122.
10. Igarashi M, Nagata A, Jinno S, Suto K, Okayama H: Wee1(+)-like gene in human cells. Nature 1991, 353:80-83.
11. Watanabe N, Broome M, Hunter T: Regulation of the human WEE1 Hu CDK tyrosine 15-kinase during the cell cycle. EMBO J 1995, 14:1878-1891. The full-length WEE1 Hu protein is identified. WEE1 Hu activity is shown to be regulated in a cell cycle dependent fashion by a complex mechanism that involves variations in the synthesis, phosphorylation and proteolytic degradation of the WEE1 Hu protein.
12. McGowan CH, Russell P: Cell cycle regulation of human WEE1. EMBO J 1995, 14:2166-2175. The molecular weight of human WEE1 is demonstrated to be approximately 94 kDa, which is substantially larger than the molecular weight of 49 kDa which was reported for the first human wee1 gene product to be identified. The authors show that WEE1 activity is strongly suppressed during M phase by a mechanism that requires phosphorylation of WEE1. Subcellular localization of p94 WEE1 shows that the protein is nuclear in location.
13. Parker LL, Sylvestre PJ, Byrnes MJ, Liu F, Piwnica-Worms H: Identification of a 95-kDa WEE1-like tyrosine kinase in HeLa cells. Proc Natl Acad Sci USA 1995, 92:9638-9642. Antibodies generated against bacterially produced p49 WEE1 Hu recognized a protein of 95 KDa in HeLa cells, but did not recognize a 49kDa protein. The authors show that the 95 kDa protein phosphorylates Cdc2 on tyrosine 15, and that this WEE1 kinase activity is impaired during mitosis.
14. Heald R, McLoughlin M, McKeon F: Human Wee1 maintains mitotic timing by protecting the nucleus from cytoplasmically activated Cdc2 kinase. Cell 1993, 74:463-474.
15. Mueller PR, Coleman TR, Kumagai A, Dunphy WG: Myt1: a membrane-associated inhibitory kinase that phosphorylates Cdc2 on both threonine-14 and tyrosine-15. Science 1995, 270:86-90.
16. Cance WG, Craven RJ, Bergman M, Xu LH, Alitalo K, Liu ET: Rak, a novel nuclear tyrosine kinase expressed in epithelial cells. Cell Growth Differ 1994, 5:1347-1355.
17. Craven RJ, Cance WG, Liu ET: The nuclear tyrosine kinase Rak associates with the retinoblastoma protein pRb. Cancer Res 1995, 55:3969-3972.
18. Greer P, Haigh J, Mbamalu G, Khoo W, Bernstein A, Pawson T: The Fps/Fes protein-tyrosine kinase promotes angiogenesis in transgenic mice. Mol Cell Biol 1994, 14:6755-6763.
19. Yates KE, Lynch MR, Wang SG, Slamon DJ, Gasson JC: Human c-Fes is a nuclear tyrosine kinase. Oncogene 1995, 10:1239-1242.
20. Hao QL, Ferris DK, White G, Heisterkamp N, Groffen J: Nuclear and cytoplasmic location of the FER tyrosine kinase. Mol Cell Biol 1991, 11:1180-1183.
21. Penhallow RC, Class K, Sonda H, Bolen JB, Rowley RB: Temporal activation of nontransmembrane protein-tyrosine kinases following mast cell FcεRI engagement. J Biol Chem 1995, 270:23362-23365.
22. Hazan B, Bern O, Carmel M, Lejbkowicz F, Goldstein RS, Nir U: FerT encodes a meiosis-specific nuclear tyrosine kinase. Cell Growth Differ 1993, 4:443-449.
23. Sawyers CL, McLaughlin J, Goga A, Havlik M, Witte O: The nuclear tyrosine kinase c-Abl negatively regulates cell growth. Cell 1994, 77:121-131. This report shows that overexpression of a kinase-defective c-Abl in fibroblasts both shortens the period of cell-cycle re-entry that follows the addition of serum to quiescent cells, and enhances transformation by Myc, Ras, v-Abl and v-Fms. The authors conclude that wild-type c-Abl is a negative regulator of cell growth.
24. + hematopoietic cells into S phase.
25. Wong KK, Hardin JD, Boast S, Cooper CL, Merrell KT, Doyle TG, Goff SP, Calame KL: A role for c-Abl in c-myc regulation. Oncogene 1995, 10:705-711.
26. Welch PJ, Wang JYJ: A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle. Cell 1993, 75:779-790.
27. Welch PJ, Wang JYJ: Abrogation of retinoblastoma protein function by c-Abl through tyrosine kinase-dependent and -independent mechanisms. Mol Cell Biol 1995, 15:5542-5551. An extension of the data presented in [26]. A mutant c-Abl that cannot bind pRb was created; this mutant is not cell cycle regulated. The activity of this pRb-resistant c-Abl is significantly elevated in quiescent cells, and remains high in S phase. In addition, the authors report that a positive growth effect is exerted by expression of wild-type c-Abl in human osteosarcoma cells. It is shown that overexpression of wild-type c-Abl can overcome pRb-induced growth arrest in these cells.
28. Kipreos ET, Wang JYJ: Differential phosphorylation of c-Abl in cell cycle determined by cdc2 kinase and phosphatase activity. Science 1990, 248:217-220.
29. Kipreos ET, Wang JYJ: Cell cycle-regulated binding of c-Abl tyrosine kinase to DNA. Science 1992, 256:382-385.
30. Baskaran R, Dahmus ME, Wang JYJ: Tyrosine phosphorylation of mammalian RNA polymerase II carboxyl-terminal domain. Proc Natl Acad Sci USA 1993, 90:11167-11171.
31. Duyster J, Baskaran R, Wang JYJ: Src homology 2 domain as a specificity determinant in the c-Abl-mediated tyrosine phosphorylation of the RNA polymerase II carboxyl-terminal repeated domain. Proc Natl Acad Sci USA 1995, 92:1555-1559.
32. Kharbanda S, Ren R, Pandey P, Shafman TD, Feller SM, Weichselbaum RR, Kufe DW: Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents. Nature 1995, 376:785-788. This important paper describes the first example of the activation of c-Abl in response to extracellular stimuli. c-Abl is activated by ionizing radiation and other DNA-damaging agents. c-Abl is required for the activation of SAPK after DNA damage.
33. Selby CP, Sancar A: Molecular mechanism of transcription-repair coupling. Science 1993, 260:53-58.
34. Drapkin R, Snacar A, Reinberg D: Where transcription meets repair. Cell 1994, 77:9-12.
35. Muller R: Transcriptional regulation during the mammalian cell cycle. Trends Genet 1995, 11:173-178.
36. Shi Y, Alin K, Goff SP: Abl-interactor-1, a novel SH3 protein binding to the carboxy-terminal portion of the Abl protein, suppresses v-Abl transforming activity. Genes Dev 1995, 9:2583-2597. This paper and [37••] describe the identification, cloning and characterization of a novel family of Abl interactor, or Abi, proteins. The two proteins identified here are highly related and interact with c-Abl. The Abi proteins are substrates of the Abl tyrosine kinase, and modulate the transforming activity of Abl.
37. ••].
38. Lu Q, Knoepfler PS, Scheele J, Wright DD, Kamps MP: Both Pbx1 and E2A-Pbx1 bind the DNA motif ATCAATCAA cooperatively with the products of multiple murine Hox genes, some of which are themselves oncogenes. Mol Cell Biol 1995, 15:3786-3795.
39. Hatano M, Roberts CWM, Minden M, Crist WM, Korsmeyer SJ: Deregulation of a homeobox gene, HOX11, by the t(10;14) in T cell leukemia. Science 1991, 253:79-82.
40. Songyang Z, Carraway KL III, Eck MJ, Harrison SC, Feldman RA, Mohammadl M, Schlessinger J, Hubbard SR, Smith DP, Eng C et al.: Catalytic specificity of protein-tyrosine kinases is critical for selective signalling. Nature 1995, 373:536-539.
41. Darnell JE, Kerr IM, Stark GR: Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994, 264:1415-1421.
42. Gertler FB, Comer AR, Juang JL, Ahern SM, Clark MJ, Liebl EC, Hoffmann FM: enabled, a dosage-sensitive suppressor of mutations in Drosophila Abl tyrosine kinase, encodes an Abl substrate with SH3 domain-binding properties. Genes Dev 1995, 9:521-533.
43. Yamanashi Y, Okada M, Semba T, Yamori T, Umemori H, Tsunasawa S, Toyoshima K, Kitamura D, Watanabe T, Yamamoto T: Identification of HS1 protein as a major substrate of protein-tyrosine kinase(s) upon B-cell antigen receptor-mediated signaling. Proc Natl Acad Sci USA 1993, 90:3631-3635.
44. src substrate. Mol Cell Biol 1991, 11:5113-5124.
45. lck. EMBO J 1995, 14:3403-3414.
46. Taniuchi I, Kitamura D, Maekawa Y, Fukuda T, Kishi H, Watanabe T: Antigen-receptor induced clonal expansion and deletion of lymphocytes are impaired in mice lacking HS1 protein, a substrate of the antigen-receptor-coupled tyrosine kinases. EMBO J 1995, 14:3664-3678. Studies of HS1-deficient mice reveal that the HS1 protein plays a role in antigen receptor derived signaling pathways in B and T cells. HS1 is also involved in clonal expansion and deletion of B and T cells.